Supersolubilization and amorphization of a weakly acidic drug, Flurbiprofen, by applying Acid-Base supersolubilization (ABS) principle.
Acid-base supersolubilization
Acidic drug
Amorphous
Dissolution
Flurbiprofen
Lysine
Meglumine
Tromethamine
pH-solubility profile
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
02 Aug 2024
02 Aug 2024
Historique:
received:
07
04
2024
revised:
21
07
2024
accepted:
31
07
2024
medline:
5
8
2024
pubmed:
5
8
2024
entrez:
4
8
2024
Statut:
aheadofprint
Résumé
Improvement in drug solubility is a major challenge for developing pharmaceutical products. It was demonstrated earlier that aqueous solubilities of weakly basic drugs could be increased greatly by interaction with weak acids that would not form salts with the drugs, and the highly concentrated solutions thus produced converted to amorphous solids upon drying. The technique was called acid-base supersolubilization (ABS). The current investigation explored whether the ABS principle could also be applied to weakly acidic drugs. By taking flurbiprofen (pK
Identifiants
pubmed: 39098746
pii: S0378-5173(24)00782-8
doi: 10.1016/j.ijpharm.2024.124548
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
124548Informations de copyright
Copyright © 2024. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.